2017
DOI: 10.1038/s41564-017-0054-x
|View full text |Cite
|
Sign up to set email alerts
|

Plasmodium UIS3 sequesters host LC3 to avoid elimination by autophagy in hepatocytes

Abstract: The causative agent of malaria, Plasmodium, replicates inside a membrane-bound parasitophorous vacuole (PV) that shields this intracellular parasite from the cytosol of the host cell1. One common threat for intracellular pathogens is the homeostatic process of autophagy through which cells capture unwanted intracellular material for lysosomal degradation2. During the liver stage of a malaria infection, Plasmodium parasites are targeted by the autophagy machinery of the host cell and the PV membrane (PVM) becom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
105
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3
3
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 91 publications
(108 citation statements)
references
References 46 publications
(64 reference statements)
3
105
0
Order By: Relevance
“…Consistent with our in vitro and in vivo data of reduced intrahepatic schizont size under metformin treatment, a shutdown of a pro-proliferative program within the host cell would limit parasite growth. In addition to suppression of pro-proliferative pathways during liver stage infection, metformin could also promote cell-autonomous host defense mechanisms, such as increased apoptosis, autophagy, lysosome-vacuole fusion, type I interferon signaling, and reactive oxygen species-mediated killing, all of which have been shown to induce parasite killing and clearance of Plasmodium-infected hepatocytes via infiltrating phagocytes (57)(58)(59)(60). Similar metformin-mediated mechanisms have been described for other intracellular pathogens, such as M. tuberculosis (25), Legionella pneumophilia (61), and hepatitis C virus (62).…”
Section: Discussionmentioning
confidence: 99%
“…Consistent with our in vitro and in vivo data of reduced intrahepatic schizont size under metformin treatment, a shutdown of a pro-proliferative program within the host cell would limit parasite growth. In addition to suppression of pro-proliferative pathways during liver stage infection, metformin could also promote cell-autonomous host defense mechanisms, such as increased apoptosis, autophagy, lysosome-vacuole fusion, type I interferon signaling, and reactive oxygen species-mediated killing, all of which have been shown to induce parasite killing and clearance of Plasmodium-infected hepatocytes via infiltrating phagocytes (57)(58)(59)(60). Similar metformin-mediated mechanisms have been described for other intracellular pathogens, such as M. tuberculosis (25), Legionella pneumophilia (61), and hepatitis C virus (62).…”
Section: Discussionmentioning
confidence: 99%
“…Among the diverse set of potato ATG8 members (Kellner et al, 2017; Zess et al, 2019), PexRD54 preferentially binds the ATG8CL isoform and outcompetes Joka2/NBR1 from ATG8CL complexes, thereby disarming defense-related autophagy at the pathogen interface. Intriguingly, PexRD54 does not fully shutdown autophagy as has been shown for animal pathogens that suppress autophagy (Choy et al, 2012; Kimmey and Stallings, 2016; Real et al, 2017; Xu et al, 2019). Instead, it stimulates formation of autophagosomes that accumulate around the pathogen interface.…”
Section: Introductionmentioning
confidence: 89%
“…Many intracellular pathogens target and subvert these trafficking events for their own benefit ( 2, 3 ). Previous work has demonstrated that the Plasmodium liver stage PV membrane co-localizes with late endosomes( 4 ), lysosomes( 5 ) and autophagic vesicles( 6 ). When this association is initiated during Plasmodium life-cycle progression remains unknown.…”
Section: Figmentioning
confidence: 99%